Dr. Iskra Pusic, MD

Medical Oncology Saint Louis, MO Female
NPI: 1164699161
Total Payments
$32,226
2024 Payments
$2,001
Companies
7
Transactions
55
Medicare Patients
2,792
Medicare Billing
$647,184

Payment Breakdown by Category

Consulting$21,885 (67.9%)
Travel$3,926 (12.2%)
Other$3,764 (11.7%)
Food & Beverage$2,482 (7.7%)
Education$169.99 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,885 9 67.9%
Travel and Lodging $3,926 19 12.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,764 1 11.7%
Food and Beverage $2,482 24 7.7%
Education $169.99 2 0.5%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $20,238 34 $0 (2023)
KADMON PHARMACEUTICALS LLC $4,507 4 $0 (2020)
SANOFI-AVENTIS U.S. LLC $3,857 2 $0 (2023)
National Marrow Donor Program $3,191 11 $0 (2024)
Astellas Pharma US Inc $169.99 2 $0 (2019)
Stemline Therapeutics Inc. $138.00 1 $0 (2022)
Celgene Corporation $125.07 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,001 5 National Marrow Donor Program ($2,001)
2023 $11,691 17 Incyte Corporation ($6,806)
2022 $7,382 12 Incyte Corporation ($7,082)
2020 $4,573 4 KADMON PHARMACEUTICALS LLC ($4,451)
2019 $6,379 15 Incyte Corporation ($6,228)
2017 $200.06 2 Celgene Corporation ($125.07)

All Payment Transactions

55 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/25/2024 National Marrow Donor Program — Consulting Fee Cash or cash equivalent $400.00 General
10/17/2024 National Marrow Donor Program — Food and Beverage In-kind items and services $771.93 General
08/07/2024 National Marrow Donor Program — Food and Beverage In-kind items and services $214.56 General
04/28/2024 National Marrow Donor Program — Food and Beverage In-kind items and services $214.51 General
04/12/2024 National Marrow Donor Program — Consulting Fee Cash or cash equivalent $400.00 General
11/30/2023 Incyte Corporation — Consulting Fee Cash or cash equivalent $5,822.00 General
11/30/2023 Incyte Corporation — Travel and Lodging Cash or cash equivalent $214.03 General
11/30/2023 Incyte Corporation — Travel and Lodging Cash or cash equivalent $158.46 General
11/30/2023 Incyte Corporation — Travel and Lodging Cash or cash equivalent $73.00 General
11/30/2023 Incyte Corporation — Travel and Lodging Cash or cash equivalent $60.00 General
11/30/2023 Incyte Corporation — Food and Beverage Cash or cash equivalent $50.00 General
11/30/2023 Incyte Corporation — Food and Beverage Cash or cash equivalent $50.00 General
11/30/2023 Incyte Corporation — Food and Beverage Cash or cash equivalent $14.97 General
11/29/2023 Incyte Corporation — Travel and Lodging Cash or cash equivalent $239.00 General
11/29/2023 Incyte Corporation — Food and Beverage Cash or cash equivalent $125.00 General
10/17/2023 SANOFI-AVENTIS U.S. LLC — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,764.00 General
10/17/2023 SANOFI-AVENTIS U.S. LLC — Food and Beverage In-kind items and services $93.46 General
10/16/2023 National Marrow Donor Program — Travel and Lodging In-kind items and services $238.18 General
10/04/2023 National Marrow Donor Program — Consulting Fee Cash or cash equivalent $200.00 General
07/05/2023 National Marrow Donor Program — Travel and Lodging In-kind items and services $189.04 General
06/30/2023 National Marrow Donor Program — Consulting Fee Cash or cash equivalent $200.00 General
04/14/2023 National Marrow Donor Program — Consulting Fee Cash or cash equivalent $200.00 General
11/27/2022 National Marrow Donor Program — Travel and Lodging In-kind items and services $162.76 General
11/04/2022 Incyte Corporation — Consulting Fee Cash or cash equivalent $5,842.50 General
11/04/2022 Incyte Corporation — Food and Beverage Cash or cash equivalent $58.44 General
123»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 34 995 29,889 $1.6M $337,162
2022 23 573 8,804 $596,657 $106,443
2021 22 563 1,763 $504,881 $108,845
2020 25 661 12,569 $341,209 $94,735
Total Patients
2,792
Total Services
53,025
Medicare Billing
$647,184
Procedure Codes
104

All Medicare Procedures & Services

104 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj Office 2023 13 3,780 $390,960 $143,904 36.8%
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg Office 2023 15 1,470 $264,600 $56,130 21.2%
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg Office 2023 25 408 $471,240 $33,086 7.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 85 476 $99,948 $29,662 29.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 64 166 $39,648 $16,001 40.4%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 85 129 $76,856 $12,749 16.6%
J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram Office 2023 15 12,240 $24,480 $9,435 38.5%
J1439 Injection, ferric carboxymaltose, 1 mg Office 2023 12 9,000 $36,000 $7,434 20.6%
38222 Biopsy and aspiration of bone marrow sample for diagnosis Office 2023 37 38 $32,072 $5,257 16.4%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 56 74 $16,650 $3,361 20.2%
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 26 49 $15,631 $2,722 17.4%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2023 33 46 $12,742 $2,322 18.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 17 17 $6,297 $1,755 27.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 13 13 $5,096 $1,722 33.8%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 40 75 $15,225 $1,639 10.8%
96375 Injection of additional new drug or substance into vein Office 2023 52 123 $17,604 $1,488 8.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 15 19 $2,869 $1,214 42.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 61 91 $6,279 $982.08 15.6%
36591 Collection of blood sample from implanted device Office 2023 27 48 $7,632 $963.70 12.6%
36415 Insertion of needle into vein for collection of blood sample Office 2023 45 100 $3,300 $840.00 25.5%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 12 12 $2,604 $768.12 29.5%
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour Office 2023 17 41 $5,125 $645.97 12.6%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 16 30 $5,700 $542.74 9.5%
J3489 Injection, zoledronic acid, 1 mg Office 2023 17 85 $9,350 $485.52 5.2%
G0009 Administration of pneumococcal vaccine Office 2023 12 16 $704.00 $479.04 68.0%
123…5»

About Dr. Iskra Pusic, MD

Dr. Iskra Pusic, MD is a Medical Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164699161.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iskra Pusic, MD has received a total of $32,226 in payments from pharmaceutical and medical device companies, with $2,001 received in 2024. These payments were reported across 55 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($21,885).

As a Medicare-enrolled provider, Pusic has provided services to 2,792 Medicare beneficiaries, totaling 53,025 services with total Medicare billing of $647,184. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.

Practice Information

  • Specialty Medical Oncology
  • Location Saint Louis, MO
  • Active Since 05/09/2008
  • Last Updated 04/17/2025
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1164699161

Products in Payments

  • ELZONRIS (Drug) $138.00
  • JAKAFI (Drug) $121.59

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Saint Louis

Dr. Brad Kahl, Md, MD

Medical Oncology — Payments: $379,829

Medical Oncology $379,829

Dr. Russell Pachynski, Md, MD

Medical Oncology — Payments: $362,594

Medical Oncology $362,594

Dr. Mark Schroeder, Md, MD

Medical Oncology — Payments: $337,205

Medical Oncology $337,205

Dr. Ravi Vij, Md, MD

Medical Oncology — Payments: $262,216

Medical Oncology $262,216

Dr. Douglas Adkins, Md, MD

Medical Oncology — Payments: $166,184

Medical Oncology $166,184

Dr. Camille Abboud, Md, MD

Medical Oncology — Payments: $155,687

Medical Oncology $155,687